FDA Warning Letter — Pleasantville Exxon

Case 627174 — FEI 3010022269

The FDA took a Warning Letter action against Pleasantville Exxon on Feb 17, 2022 (Pleasantville, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Pleasantville Exxon
Date
Feb 17, 2022
Fiscal Year
2022
Product Type
Tobacco
Center
CTP
Location
Pleasantville, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.